Trial Outcomes & Findings for Dietary Fat, Eicosanoids and Breast Cancer Risk (NCT NCT01824498)
NCT ID: NCT01824498
Last Updated: 2018-08-31
Results Overview
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
18 participants
Primary outcome timeframe
8 weeks
Results posted on
2018-08-31
Participant Flow
* 6 * 137 participants screened, 66 did not meet criteria, 71 were eligible but 39 declined participation,32 screened in clinic but 2 didn't meet eligibility on further screen and 6 declined participation
Subjects enrolled prior to randomization (N=18)
Participant milestones
| Measure |
Low Fat, High Fat, Low Fat High Omega 3
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
Low Fat, Low Fat High Omega 3, High Fat
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
High Fat, Low Fat, Low Fat High Omega 3
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
High Fat, Low Fat High Omega 3, Low Fat
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
Low Fat High Omega 3, High Fat, Low Fat
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
Low Fat High Omega 3, Low Fat, High Fat
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
|---|---|---|---|---|---|---|
|
1st Intervention (8 Weeks)
STARTED
|
5
|
2
|
6
|
3
|
4
|
4
|
|
1st Intervention (8 Weeks)
COMPLETED
|
5
|
2
|
6
|
3
|
4
|
4
|
|
1st Intervention (8 Weeks)
NOT COMPLETED
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Washout (8 Weeks)
STARTED
|
3
|
2
|
4
|
2
|
3
|
4
|
|
Washout (8 Weeks)
COMPLETED
|
3
|
2
|
4
|
2
|
3
|
4
|
|
Washout (8 Weeks)
NOT COMPLETED
|
0
|
0
|
0
|
0
|
0
|
0
|
|
2nd Intervention (8 Weeks)
STARTED
|
3
|
2
|
4
|
2
|
3
|
4
|
|
2nd Intervention (8 Weeks)
COMPLETED
|
3
|
2
|
4
|
2
|
3
|
4
|
|
2nd Intervention (8 Weeks)
NOT COMPLETED
|
0
|
0
|
0
|
0
|
0
|
0
|
|
3rd Intervention (8 Weeks)
STARTED
|
3
|
2
|
4
|
2
|
3
|
4
|
|
3rd Intervention (8 Weeks)
COMPLETED
|
3
|
2
|
4
|
2
|
3
|
4
|
|
3rd Intervention (8 Weeks)
NOT COMPLETED
|
0
|
0
|
0
|
0
|
0
|
0
|
Reasons for withdrawal
| Measure |
Low Fat, High Fat, Low Fat High Omega 3
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
Low Fat, Low Fat High Omega 3, High Fat
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
High Fat, Low Fat, Low Fat High Omega 3
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
High Fat, Low Fat High Omega 3, Low Fat
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
Low Fat High Omega 3, High Fat, Low Fat
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
Low Fat High Omega 3, Low Fat, High Fat
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
|---|---|---|---|---|---|---|
|
Washout (8 Weeks)
Withdrawal by Subject
|
2
|
0
|
2
|
1
|
1
|
0
|
Baseline Characteristics
Dietary Fat, Eicosanoids and Breast Cancer Risk
Baseline characteristics by cohort
| Measure |
Low Fat, High Fat, Low Fat High Omega 3
n=5 Participants
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
Low Fat, Low Fat High Omega 3, High Fat
n=2 Participants
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
High Fat, Low Fat, Low Fat High Omega 3
n=6 Participants
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
High Fat, Low Fat High Omega 3, Low Fat
n=3 Participants
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
Low Fat High Omega 3, High Fat, Low Fat
n=4 Participants
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
Low Fat High Omega 3, Low Fat, High Fat
n=4 Participants
Low Fat = 20% fat High Fat = 40% fat Low Fat, high n3 diet = 20% fat + 3% n3
|
Total
n=24 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=10 Participants
|
0 Participants
n=115 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
5 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
3 Participants
n=4 Participants
|
4 Participants
n=21 Participants
|
4 Participants
n=10 Participants
|
24 Participants
n=115 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=10 Participants
|
0 Participants
n=115 Participants
|
|
Age, Continuous
|
57 years
STANDARD_DEVIATION 2 • n=5 Participants
|
57 years
STANDARD_DEVIATION 2 • n=7 Participants
|
57 years
STANDARD_DEVIATION 2 • n=5 Participants
|
57 years
STANDARD_DEVIATION 2 • n=4 Participants
|
57 years
STANDARD_DEVIATION 2 • n=21 Participants
|
57 years
STANDARD_DEVIATION 2 • n=10 Participants
|
57 years
STANDARD_DEVIATION 2 • n=115 Participants
|
|
Sex: Female, Male
Female
|
5 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
3 Participants
n=4 Participants
|
4 Participants
n=21 Participants
|
4 Participants
n=10 Participants
|
24 Participants
n=115 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=10 Participants
|
0 Participants
n=115 Participants
|
|
Region of Enrollment
United States
|
5 participants
n=5 Participants
|
2 participants
n=7 Participants
|
6 participants
n=5 Participants
|
3 participants
n=4 Participants
|
4 participants
n=21 Participants
|
4 participants
n=10 Participants
|
24 participants
n=115 Participants
|
PRIMARY outcome
Timeframe: 8 weeksOutcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: 8 weeksEstradiol
Outcome measures
| Measure |
High Fat Diet
n=18 Participants
Hig fat diet = 40% fat
|
Low Fat Diet
n=18 Participants
Low fat diet = 20% fat
|
Low Fat, High n3 Diet
n=18 Participants
Low fat, n3 diet = 20% fat + 3% n3
|
|---|---|---|---|
|
E2
|
52.8 pmol/L
Standard Error 5.1
|
35.6 pmol/L
Standard Error 5.4
|
39.8 pmol/L
Standard Error 5.1
|
Adverse Events
High Fat Diet
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Low Fat Diet
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Low Fat, High n3 Diet
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place